|
US6972193B1
(en)
*
|
1993-02-12 |
2005-12-06 |
Board Of Trustees Of Leland Stanford Junior University |
Regulated transcription of targeted genes and other biological events
|
|
US6891021B2
(en)
*
|
1993-02-12 |
2005-05-10 |
Board Of Trustees Of The Leland Stanford Junior University |
Regulated apoptosis
|
|
JP2002544285A
(ja)
*
|
1999-05-14 |
2002-12-24 |
メディカル リサーチ カウンシル |
オリゴマーシャペロンタンパク質
|
|
JP2003502024A
(ja)
*
|
1999-05-14 |
2003-01-21 |
メディカル リサーチ カウンシル |
タンパク質骨格および単量体ポリペプチドを多量体化するためのその使用
|
|
WO2000071743A1
(fr)
*
|
1999-05-25 |
2000-11-30 |
Eisai Co., Ltd. |
Methode bihybride dans une cellule de mammifere
|
|
JP2003501043A
(ja)
*
|
1999-05-28 |
2003-01-14 |
ターゲティッド ジェネティクス コーポレイション |
腫瘍壊死因子（ｔｎｆ）関連障害において、ｔｎｆのレベルを低下させるための方法および組成物
|
|
CA2369855A1
(en)
*
|
1999-05-28 |
2001-01-04 |
Sangamo Biosciences, Inc. |
Molecular switches
|
|
US7057015B1
(en)
|
1999-10-20 |
2006-06-06 |
The Salk Institute For Biological Studies |
Hormone receptor functional dimers and methods of their use
|
|
WO2001036623A2
(en)
*
|
1999-11-05 |
2001-05-25 |
Avigen, Inc. |
Ecdysone-inducible adeno-associated virus expression vectors
|
|
US20020004202A1
(en)
|
2000-01-24 |
2002-01-10 |
Cornish Virginia W. |
In vivo screen using chemical inducers of dimerization
|
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
|
AU2001249315A1
(en)
*
|
2000-03-22 |
2001-10-03 |
Rheogene, Inc. |
Ecdysone receptor-based inducible gene expression system
|
|
EP1290196A1
(en)
*
|
2000-06-16 |
2003-03-12 |
Ariad Gene Therapeutics, Inc. |
Chimeric hsf transcription factors
|
|
JP2004504029A
(ja)
*
|
2000-07-18 |
2004-02-12 |
ノバルティス アクチエンゲゼルシャフト |
単鎖、一量体、リガンド依存性ポリペプチドスイッチを用いる遺伝子発現の調節
|
|
US7011972B2
(en)
|
2000-07-18 |
2006-03-14 |
The Scripps Research Institute |
Fusion polypeptide comprising two ligand binding domains
|
|
EP1303608A2
(en)
*
|
2000-07-21 |
2003-04-23 |
Syngenta Participations AG |
Zinc finger domain recognition code and uses thereof
|
|
US8105825B2
(en)
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
|
US6576422B1
(en)
*
|
2000-10-17 |
2003-06-10 |
Rohm And Haas Company |
Method for identifying products employing gene expression
|
|
DK1534738T3
(da)
|
2001-02-20 |
2012-10-01 |
Intrexon Corp |
Nye substitutionsmutantreceptorer og anvendelse heraf i et inducérbart genekpressionssystem på basis af en nuklear receptor
|
|
JP4328094B2
(ja)
|
2001-02-20 |
2009-09-09 |
イントレクソン・コーポレイション |
新規置換突然変異体受容体および核受容体−ベースの誘導性遺伝子発現システムにおけるその使用
|
|
US9493540B2
(en)
|
2001-02-20 |
2016-11-15 |
Intrexon Corporation |
Ecdysone receptor/invertebrate retinoid X receptor-based inducible gene expression system
|
|
WO2002066614A2
(en)
|
2001-02-20 |
2002-08-29 |
Rheogene Holdings, Inc. |
Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
|
|
CA2439263C
(en)
*
|
2001-03-02 |
2012-10-23 |
Frank Becker |
Three hybrid assay system
|
|
WO2003016496A2
(en)
*
|
2001-08-20 |
2003-02-27 |
The Scripps Research Institute |
Zinc finger binding domains for cnn
|
|
CA2458224A1
(en)
*
|
2001-08-23 |
2003-03-06 |
The Regents Of The University Of California |
A universal light-switchable gene promoter system
|
|
US20030064053A1
(en)
*
|
2001-08-31 |
2003-04-03 |
Shengjiang Liu |
Multivalent protein conjugate with multiple ligand-binding domains of receptors
|
|
EP1436394A4
(en)
|
2001-09-26 |
2004-12-29 |
Rheo Gene Holdings Inc |
CICADA ECDYSON RECEPTOR NUCLEIC ACIDS, POLYPEPTIDES AND THEIR USE
|
|
EP1440319A2
(en)
*
|
2001-10-01 |
2004-07-28 |
BioImage A/S |
An improved method to detect interactions between cellular components in intact living cells, and to extract quantitative information relating to those interactions by fluorescence redistribution
|
|
US8119365B2
(en)
*
|
2002-01-23 |
2012-02-21 |
Wisconsin Alumni Research Foundation |
Insertion sequence-free bacteria
|
|
US8765408B2
(en)
|
2002-01-23 |
2014-07-01 |
Wisconsin Alumni Research Foundation |
Prophage element-free bacteria
|
|
US8039243B2
(en)
*
|
2002-01-23 |
2011-10-18 |
Wisconsin Alumni Research Foundation |
Insertion sequence-free bacteria
|
|
US6989265B2
(en)
*
|
2002-01-23 |
2006-01-24 |
Wisconsin Alumni Research Foundation |
Bacteria with reduced genome
|
|
US20060270043A1
(en)
*
|
2002-01-23 |
2006-11-30 |
Blattner Frederick R |
Bacteria with reduced genome
|
|
JP4547911B2
(ja)
|
2002-02-01 |
2010-09-22 |
アリアド・ファーマシューティカルズ・インコーポレイテッド |
リン含有化合物およびその用途
|
|
US6845929B2
(en)
*
|
2002-03-22 |
2005-01-25 |
Ali Dolatabadi |
High efficiency nozzle for thermal spray of high quality, low oxide content coatings
|
|
US7083918B2
(en)
|
2002-04-24 |
2006-08-01 |
The Trustees Of Columbia University In The City Of New York |
Bacterial small-molecule three-hybrid system
|
|
US8673589B2
(en)
|
2002-05-29 |
2014-03-18 |
Regeneron Pharmaceuticals, Inc. |
Inducible eukaryotic expression system
|
|
EP1531666B1
(en)
*
|
2002-05-29 |
2013-10-23 |
Regeneron Pharmaceuticals, Inc. |
Inducible eukaryotic expression system
|
|
US7303906B2
(en)
*
|
2002-09-06 |
2007-12-04 |
Wisconsin Alumni Research Foundation |
Competent bacteria
|
|
CA2503787A1
(en)
*
|
2002-11-05 |
2004-05-27 |
Regeneron Pharmaceuticals, Inc. |
Methods of isolation of active compounds and activated targets
|
|
US7385027B2
(en)
*
|
2003-01-07 |
2008-06-10 |
University Of Kentucky Research Foundation |
Membrane-permeable peptide capable of calpain inhibition
|
|
US7304161B2
(en)
|
2003-02-10 |
2007-12-04 |
Intrexon Corporation |
Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
|
|
US7456315B2
(en)
|
2003-02-28 |
2008-11-25 |
Intrexon Corporation |
Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
|
US20050136035A1
(en)
*
|
2003-06-03 |
2005-06-23 |
Derek Ko |
Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
|
|
JP4644663B2
(ja)
*
|
2003-06-03 |
2011-03-02 |
セル ジェネシス インコーポレイテッド |
ペプチド開裂部位を用いた単一ベクターからの組換えポリペプチドの高められた発現のための構成と方法
|
|
US7935510B2
(en)
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
US7714119B2
(en)
*
|
2004-07-13 |
2010-05-11 |
Biosante Pharmaceuticals, Inc. |
AAV vector compositions and methods for enhanced expression of immunoglobulins using the same
|
|
US7632509B2
(en)
|
2005-07-19 |
2009-12-15 |
Biosante Pharmaceuticals, Inc. |
Methods to express recombinant proteins from lentiviral vectors
|
|
US20070292922A1
(en)
*
|
2006-03-31 |
2007-12-20 |
Cell Genesys, Inc. |
Regulated expression of recombinant proteins from adeno-associated viral vectors
|
|
KR101666228B1
(ko)
|
2007-09-28 |
2016-10-13 |
인트렉손 코포레이션 |
생물치료학적 분자를 발현시키기 위한 치료학적 유전자-스위치 작제물 및 생물반응기, 및 이의 용도
|
|
CN103038343A
(zh)
|
2010-03-23 |
2013-04-10 |
英特瑞克斯顿股份有限公司 |
条件表达治疗蛋白的载体，包含所述载体的宿主细胞，及其应用
|
|
SG10201908848RA
(en)
|
2010-03-29 |
2019-10-30 |
Univ Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
US9315825B2
(en)
|
2010-03-29 |
2016-04-19 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
WO2012122025A2
(en)
|
2011-03-04 |
2012-09-13 |
Intrexon Corporation |
Vectors conditionally expressing protein
|
|
EP2699688A1
(en)
|
2011-04-20 |
2014-02-26 |
The Trustees Of The University Of Pennsylvania |
Regimens and compositions for aav-mediated passive immunization of airborne pathogens
|
|
WO2014100913A1
(en)
*
|
2012-12-24 |
2014-07-03 |
Beijing Anxinhuaide Biotech. Co., Ltd |
Improving the half life of a therapeutic polypeptide by fusing with a trimeric scaffold protein via a spacer
|
|
RU2637946C2
(ru)
|
2013-03-15 |
2017-12-08 |
Интрексон Корпорейшн |
Борсодержащие диацилгидразины
|
|
US9719106B2
(en)
|
2013-04-29 |
2017-08-01 |
The Trustees Of The University Of Pennsylvania |
Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
|
|
SG11201609211VA
(en)
*
|
2014-03-05 |
2016-12-29 |
Nat Univ Corp Univ Kobe |
Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same
|
|
EP3194359B1
(en)
|
2014-09-17 |
2020-04-08 |
Intrexon Corporation |
Boron-containing diacylhydrazine compounds
|
|
DK3216867T3
(da)
*
|
2014-11-04 |
2020-06-22 |
Univ Kobe Nat Univ Corp |
Fremgangsmåde til at modificere genomsekvens for at introducere specifik mutation i tilsigtet dna-sekvens ved base-fjernelsesreaktion og molekylekompleks anvendt dertil
|
|
US11535665B2
(en)
|
2015-05-13 |
2022-12-27 |
The Trustees Of The University Of Pennsylvania |
AAV-mediated expression of anti-influenza antibodies and methods of use thereof
|
|
WO2017062953A1
(en)
|
2015-10-10 |
2017-04-13 |
Intrexon Corporation |
Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12
|
|
WO2017075335A1
(en)
|
2015-10-28 |
2017-05-04 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
|
WO2017090761A1
(ja)
|
2015-11-27 |
2017-06-01 |
国立大学法人神戸大学 |
標的化したｄｎａ配列の核酸塩基を特異的に変換する、単子葉植物のゲノム配列の変換方法、及びそれに用いる分子複合体
|
|
IL322403A
(en)
|
2016-04-15 |
2025-09-01 |
Univ Pennsylvania |
Preparations for the treatment of wet age-related macular degeneration
|
|
UY37343A
(es)
|
2016-07-25 |
2018-02-28 |
Intrexon Corp |
Control del fenotipo en plantas
|
|
IL266358B2
(en)
|
2016-11-09 |
2025-10-01 |
Precigen Inc |
Constructs for Prataxin Expression
|
|
SI3589730T1
(sl)
|
2017-02-28 |
2024-04-30 |
The Trustees Of The University Of Pennsylvania |
Adeno-povezan virus (AAV) clade F vektor in njihova uporaba
|
|
US10786568B2
(en)
|
2017-02-28 |
2020-09-29 |
The Trustees Of The University Of Pennsylvania |
AAV mediated influenza vaccines
|
|
JOP20190200A1
(ar)
|
2017-02-28 |
2019-08-27 |
Univ Pennsylvania |
تركيبات نافعة في معالجة ضمور العضل النخاعي
|
|
CN111727201A
(zh)
|
2017-10-18 |
2020-09-29 |
再生生物股份有限公司 |
完全人源翻译后修饰的抗体治疗剂
|
|
CA3079565A1
(en)
|
2017-10-18 |
2019-04-25 |
Regenxbio Inc. |
Treatment of ocular diseases and metastatic colon cancer with human post-translationally modified vegf-trap
|
|
US12558434B2
(en)
|
2018-02-20 |
2026-02-24 |
The Trustees Of The University Of Pennsylvania |
Compositions for treatment of wet age-related macular degeneration
|
|
EP3946467A1
(en)
|
2019-04-03 |
2022-02-09 |
REGENXBIO Inc. |
Gene therapy for eye pathologies
|
|
WO2020219868A1
(en)
|
2019-04-24 |
2020-10-29 |
Regenxbio Inc. |
Fully-human post-translationally modified antibody therapeutics
|
|
CN114502197A
(zh)
|
2019-08-26 |
2022-05-13 |
再生生物股份有限公司 |
用全人经翻译后修饰的抗VEGF Fab治疗糖尿病性视网膜病变
|
|
US20240108669A1
(en)
|
2019-10-07 |
2024-04-04 |
Regenxbio Inc. |
Adeno-associated virus vector pharmaceutical composition and methods
|
|
WO2022060915A1
(en)
|
2020-09-15 |
2022-03-24 |
Regenxbio Inc. |
Vectorized lanadelumab and administration thereof
|
|
EP4214242A1
(en)
|
2020-09-15 |
2023-07-26 |
RegenxBio Inc. |
Vectorized antibodies for anti-viral therapy
|
|
KR20230083287A
(ko)
|
2020-10-07 |
2023-06-09 |
리젠엑스바이오 인크. |
Cln2 질환의 안구 징후에 대한 유전자 요법
|
|
TW202233841A
(zh)
|
2020-10-28 |
2022-09-01 |
美商銳進科斯生物股份有限公司 |
用於眼適應症之載體化抗ＴＮＦ－α抗體
|
|
WO2022094157A1
(en)
|
2020-10-28 |
2022-05-05 |
Regenxbio Inc. |
Vectorized anti-cgrp and anti-cgrpr antibodies and administration thereof
|
|
CN116457373A
(zh)
|
2020-10-29 |
2023-07-18 |
再生生物股份有限公司 |
用于眼部适应症的载体化TNF-α拮抗剂
|
|
EP4236974A2
(en)
|
2020-10-29 |
2023-09-06 |
RegenxBio Inc. |
Vectorized factor xii antibodies and administration thereof
|
|
EP4256065A2
(en)
|
2020-12-01 |
2023-10-11 |
The Trustees of The University of Pennsylvania |
Novel compositions with tissue-specific targeting motifs and compositions containing same
|
|
EP4334334A1
(en)
|
2021-04-23 |
2024-03-13 |
The Trustees of The University of Pennsylvania |
Novel compositions with brain-specific targeting motifs and compositions containing same
|
|
US20240384298A1
(en)
|
2021-10-02 |
2024-11-21 |
The Trustees Of The University Of Pennsylvania |
Novel aav capsids and compositions containing same
|
|
KR20240137067A
(ko)
|
2022-01-25 |
2024-09-19 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
개선된 심장 형질도입 및 간의 탈표적화를 위한 aav 캡시드
|
|
EP4507741A1
(en)
|
2022-04-14 |
2025-02-19 |
RegenxBio Inc. |
Gene therapy for treating an ocular disease
|
|
US20250277004A1
(en)
|
2022-04-18 |
2025-09-04 |
Regenxbio Inc. |
Hybrid aav capsids
|
|
TW202400803A
(zh)
|
2022-05-03 |
2024-01-01 |
美商銳進科斯生物股份有限公司 |
載體化抗補體抗體與補體劑及其投與
|
|
US20250288697A1
(en)
|
2022-05-03 |
2025-09-18 |
Regenxbio Inc. |
Vectorized anti-tnf-alpha inhibitors for ocular indications
|
|
US20260034250A1
(en)
|
2022-09-30 |
2026-02-05 |
Regenxbio Inc. |
Treatment of ocular diseases with recombinant viral vectors encoding anti-vegf fab
|
|
KR20250135916A
(ko)
|
2022-12-17 |
2025-09-15 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
심장 및 골격근 특이적 표적화 모티프를 갖는 재조합 aav 돌연변이체 벡터 및 이를 포함하는 조성물
|
|
WO2024130070A2
(en)
|
2022-12-17 |
2024-06-20 |
The Trustees Of The University Of Pennsylvania |
Recombinant aav capsids with cardiac- and skeletal muscle- specific targeting motifs and uses thereof
|
|
AU2024271004A1
(en)
|
2023-05-16 |
2026-01-15 |
Regenxbio Inc. |
Vectorized anti-complement antibodies and administration thereof
|
|
WO2024238859A1
(en)
|
2023-05-16 |
2024-11-21 |
Regenxbio Inc. |
Vectorized c5 inhibitor agents and administration thereof
|
|
TW202516019A
(zh)
|
2023-06-29 |
2025-04-16 |
賓州大學委員會 |
具中樞神經系統靶向模體的突變aav及含有其之組成物
|
|
WO2025102034A1
(en)
|
2023-11-10 |
2025-05-15 |
The Trustees Of The University Of Pennsylvania |
Gene therapy for barth syndrome
|
|
WO2025106661A1
(en)
|
2023-11-14 |
2025-05-22 |
The Trustees Of The University Of Pennsylvania |
Compositions with cardiac and skeletal musclespecific targeting motifs and uses thereof
|
|
TW202548025A
(zh)
|
2024-04-08 |
2025-12-16 |
美商銳進科斯生物股份有限公司 |
載體化抗補體抗體與補體劑及其投與
|